Beyond Efficacy: Unveiling the Mechanisms of Change in Psychotherapy
Behavioral Health Treatments with Newport Healthcare
November 2025
We know psychotherapy works—but why? This presentation will highlight the ongoing debate about what leads to change in psychotherapy and the implications for training and supervision.
Roeske examines the efficacy and limitations of empirically supported treatments (ESTs), as well as evidence that common factors—like therapeutic alliance, empathy, and client characteristics—may be more important. He reviews common factors theory and explores compelling evidence supporting the contextual model—a prominent example of this theory—and why experienced therapists gravitate toward these models in practice.
Learning objectives
By the end of this webinar, participants can:
-
Describe the difference between specific factors and common factors in psychotherapy.
-
Evaluate the evidence supporting the impact of common factors on psychotherapy outcomes.
-
Explain the role of common factors in psychotherapy training and supervision.
Presenter Disclaimer
Michael Roeske, PsyD, has a working relationship with Newport Healthcare. As such, he has both a financial and an intellectual interest in the webinar content. The purpose of this presentation is to provide a balanced view on the ongoing debate about what leads to change in psychotherapy and the implications for training and supervision.
This program does not offer CE credit.
Paid for by
These topical webinars for APA members are paid for by Newport Healthcare. The content was created by Newport Healthcare and does not reflect the views of APA or its editorial staff. Email Advertising to learn more. Newport Healthcare is the national leader in behavioral health treatment for children, teens, and young adults, providing sustainable healing for mental health and co-occurring disorders.
Presenter
Michael Roeske, PsyD
Senior director, Newport Healthcare Center for Research and Innovation.
More in this series
Mirela Loftus, MD, PhD, discusses identifying and treating depression and anxiety in adolescents and young adults
May 2025 On Demand Webinar
Michael Roeske, PsyD, examines cannabis and psychosis, covering trends, treatment, and societal disparities related to both issues
September 2024 On Demand Webinar
About one in seven young adults in the United States has a co-occurring mental illness and substance use disorder
November 2023 On Demand Webinar
Discusses the hypothetical implications of the brain opioid theory of social attachment by addressing several common and important topics not covered in the previous training
November 2022 On Demand Webinar

